(NAMC) - Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has stated that the Company's saliva-based version of its NicAlert(TM) product for testing for tobacco use or exposure has now achieved certification in Europe with the CE Mark. The CE Mark indicates that the product complies with EU safety, environmental, and quality standards and makes the product eligible for sale in the European Union.

The new product uses easily obtainable saliva samples and can provide accurate on-site test results within minutes.

NAMC Newswire Note: The Wall Street to Main Street daily segment in its entirety will only be available to subscribers. Subscriptions are FREE , just go to www.namcnewswire.com and add your email address to receive the full segments as they are released. All email addresses are kept confidential and are only used for NAMC and not shared wtih third parties.

Wall Street to Main Street and The NAMC Radio can now be listened to on StreetIQ.com,  the leader in financial Podcast:
http://www.streetiq.com/dir/NAMC.shtml

To keep up to date with companies that we report on just register to receive Wall Street to Main Street in your email box every morning FREE. We feature companies that trade on the NYSE, AMEX, NASDAQ, OTCBB and Overseas, Keeping our readers informed daily. Just go to our site and register, it’s simple and free, www.namcnewswire.com . Also be sure to visit the NAMC radio at www.namcnewswire.com/namcradio for the latest radio segments of Wall Street to Main Street.